Heterogeneous Reduction in Paediatric RSV Hospitalisations Following Regional Nirsevimab Immunisation Strategies: A Multicentre Study

Study limitation reported by the research below: “Sample size (n=10,915) reflects total RSV hospitalisations across six seasons, not individual patients enrolled in a prospective study.”